Inovio Pharmaceuticals GAAP EPS of -$0.61 in-line

2 hours ago 1

Inovio Pharmaceuticals press release (NASDAQ:INO): Q2 GAAP EPS of -$0.61 in-line.
As of June 30, 2025, cash, cash equivalents and short-term investments were $47.5 million (excluding net proceeds from the July 2025 offering of $22.5 million), compared to $94.1 million as of December 31, 2024.

Recommended For You